| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
| mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.9 |
| mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
Imatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
0.0024 |
0.9 |